Modulation of Arc has further been implicated in several neurological disorders including Alzheimer's disease (AD), schizophrenia, depression, autism, Angelman syndrome, and Fragile X syndrome (Gallo et al., 2018; Wilkerson et al., 2018). Here, ARC is linked to depressive symptom measurement.